A RANDOMIZED CONTROLLED TRIAL TO ASSESS THE EFFECTIVENESS OF INDIVIDUALIZED HOMOEOPATHIC MEDICINES IN ACUTE PAIN - NI

Tantia University0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月29日

试验速览

暂无简介。

•1. All the patients presenting with acute pain.
•2. Patients of all age group and both sexes.
•3. Patients taking a prescription medication (NSAIDs, acetaminophen, and aspirin) episodically (or as needed) for the management of pain, agrees to discontinue its use prior to or at the Screening and Baseline Visit
•4. Patients agreeing to not commence any new prescription medication for the management of pain
•throughout the study
•5. Patients agreeing to not commence any injection therapy for pain during the course of the study
•6. Patients agreeing to not use acupuncture, biofeedback, or transcutaneous electrical nerve
•stimulation (TENS) for the management of pain during the course of the study.

•1. Terminally ill patients. [eg. congestive heart failure, renal failure or dialysis etc.]
•2. Patients unwilling to give the consent.
•3. Patients with pre-existing opiate therapy; and patients with dependencies on tobacco, alcohol, opioids, or other substances.
•4. Patients with angina, bronchospasm, bronchial asthma, bronchospasm (chronic obstructive pulmonary disease and emphysema), diabetes mellitus, hyperthyroidism, fibromyalgia, or uncontrolled seizures or known hypersensitivity.
•5. Anything that, in the opinion of the investigator, would place the participant at
•increased risk or preclude the participant’s full compliance with or completion of the study

发起方

Tantia University